Position in ANRO
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$226,030
New position
Shares Held
8,565
first reported quarter
Ownership
0.024%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#2
of 5 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GK Wealth Management LLC holds $1,849,302 across 6 Biotechnology names. ANRO ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
6,188 | $701,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
922 | $457,985 | |
| 3 | ANRO |
Alto Neuroscience, Inc.
This page
|
8,565 | $226,030 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
337 | $210,132 | |
| 5 | ARDX |
Ardelyx, Inc.
|
40,868 | $208,426 | |
| 6 | ELDN |
Eledon Pharmaceuticals, Inc.
|
11,487 | $45,258 |
All Filings in ANRO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,030 | 8,565 | Shares | Defined | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||